Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.45934
Abstract: Key Points Question Is delayed adjuvant hormone therapy (AHT) associated with reduced survival in patients with hormone receptor–positive breast cancer? Findings In this cohort study of 144 103 US patients with hormone receptor–positive/human epidermal growth factor… read more here.
Keywords: survival; receptor positive; hormone receptor; breast cancer ... See more keywords
Statin use in patients with hormone receptor‐positive metastatic breast cancer treated with everolimus and exemestane
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5369
Abstract: We analyzed the effect of statins in patients with hormone receptor‐positive (HR+) metastatic breast cancer treated with everolimus + exemestane (EverX). read more here.
Keywords: receptor positive; hormone receptor; positive metastatic; metastatic breast ... See more keywords
Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "eLife"
DOI: 10.7554/elife.83045
Abstract: Background: More than half of Chinese patients with hormone receptor positive (HR+) ductal carcinoma in situ (DCIS) are treated with mastectomy, and usually followed by endocrine therapy (ET). Given that long-term ET can cause severe… read more here.
Keywords: safety; receptor positive; hormone receptor; mastectomy ... See more keywords